Merck to Seek Emergency Authorization for Pill That Cuts COVID-19 Death Risk in Half

Merck and Ridgeback Biotherapeutics said that molnupiravir, a pill.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting